Minocycline HCl

Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation). 

Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue 

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.

A ni ọpọlọpọ awọn ile-iṣelọpọ giga-giga pẹlu ifowosowopo jinlẹ, eyiti o le fun ọ ni awọn ọja to gaju ati awọn idiyele ifigagbaga. Ati pe a tun le fun awọn ẹdinwo fun awọn rira olopobobo.Ati pe a ṣe ifọwọsowọpọ pẹlu ọpọlọpọ awọn ile-iṣẹ gbigbe ẹru ẹru ọjọgbọn, le fi awọn ọja ranṣẹ lailewu ati laisiyonu si ọwọ rẹ. Akoko ifijiṣẹ jẹ nipa awọn ọjọ 3-20 lẹhin ijẹrisi isanwo.

Minocycline Hydrochloride is a semisynthetic tetracycline class,broad-spectrum antibiotics in the tetracycline class of antibiotics,the product of the strongest activity.To gram-positive bacteria including tetracycline resistance of staphylococcus aureus,streptococcus and gram-negative bacteria such as gonorrhea netheril bacteria have a strong role; For chlamydia trachomatis and dissolving urea mycoplasma also has better inhibition.

1. Ṣe o jẹ ile-iṣẹ tabi ile-iṣẹ iṣowo kan?
A jẹ ile-iṣẹ iṣọpọ compnay ati iṣowo, ti n pese iṣẹ iduro kan.OEM le gba.

2. Ṣe o pese awọn ayẹwo? Ṣe o jẹ ọfẹ tabi afikun?
Awọn ayẹwo ọfẹ.Ọya ẹru ọkọ ayẹwo naa nilo lati san nipasẹ ẹgbẹ rẹ.

3. Ṣe o ni awọn iwe-ẹri eyikeyi ti o ni ibatan si iṣakoso didara?
ISO 9001: 2008 iwe-ẹri lati rii daju didara.

4. Kini MO yẹ ki n pese lati gba agbasọ ọrọ kan?
Pls sọ fun wa iru ọja ti o nilo, iwọn ibere, adirẹsi ati awọn ibeere pataki.Itọkasi yoo ṣee ṣe fun itọkasi rẹ ni akoko.

5. Iru ọna sisan wo ni o fẹ? Iru awọn ofin wo ni a gba?
Awọn ofin Ifijiṣẹ ti a gba: FOB, CFR, CIF, EXW;
Ti gba Owo Isanwo:USD;
Ti gba Isanwo Isanwo: T/T,Western Union; Paypal, Iṣowo Iṣowo.
Ede Sọ: Gẹẹsi.